2019-2023 France Drugs of Abuse Testing Market: Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
![](/report_cover/2215/2019-2023-france-drugs-of-abuse-testing-market-supplier-shares-n-segment-forecasts-by-test-competitive-intelligence-emerging-technologies-instrumentatio_en.gif)
This new 260-page report from LeadingMarketResearch.com provides a comprehensive analysis of the French drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.
During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
This report is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.
Contains 260 pages and 10 tables
The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.
During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
This report is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.
Contains 260 pages and 10 tables
INTRODUCTION
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Drugs of Abuse
1. Overview
2. Test Methodologies
3. Amphetamines
4. Barbiturates
5. Benzodiazepines
6. Cannabinoids/Marijuana
7. Cocaine
8. Lysergic Acid Diethylamide (LSD)
9. Methadone
10. Methaqualone
11. Opiates
12. Phencyclidine
13. Tricyclic Antidepressants
B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers manufactured by Abaxis, Abbott, Alere/Inverness, Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba, Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
C. Major In Vitro Diagnostic Technologies And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
D. Market Size, Growth and Major Supplier Shares
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott Laboratories
AdnaGen/Alere
Agilent Technologies
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio
Grifols
Instrumentation Laboratory
Kyowa Medex
Matritech/Alere
Ortho-Clinical Diagnostics
Quest Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Drugs of Abuse
1. Overview
2. Test Methodologies
3. Amphetamines
4. Barbiturates
5. Benzodiazepines
6. Cannabinoids/Marijuana
7. Cocaine
8. Lysergic Acid Diethylamide (LSD)
9. Methadone
10. Methaqualone
11. Opiates
12. Phencyclidine
13. Tricyclic Antidepressants
B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers manufactured by Abaxis, Abbott, Alere/Inverness, Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba, Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
C. Major In Vitro Diagnostic Technologies And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
D. Market Size, Growth and Major Supplier Shares
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott Laboratories
AdnaGen/Alere
Agilent Technologies
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio
Grifols
Instrumentation Laboratory
Kyowa Medex
Matritech/Alere
Ortho-Clinical Diagnostics
Quest Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE
LIST OF TABLES
Major Companies Developing or Marketing Drugs of Abuse Tests
France, Drugs of Abuse Test Volume Forecast By Market Segment
France, All Market Segments, Drugs Of Abuse Test Volume Forecast by Assay
France, Hospital Laboratories, Drugs Of Abuse Test Volume Forecast by Assay
France, Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
France, Drugs of Abuse Reagent Market Forecast By Market Segment
France, All Market Segments, Drugs of Abuse Reagent Market Forecast by Assay
France, Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
France, Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
France, Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
Major Companies Developing or Marketing Drugs of Abuse Tests
France, Drugs of Abuse Test Volume Forecast By Market Segment
France, All Market Segments, Drugs Of Abuse Test Volume Forecast by Assay
France, Hospital Laboratories, Drugs Of Abuse Test Volume Forecast by Assay
France, Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
France, Drugs of Abuse Reagent Market Forecast By Market Segment
France, All Market Segments, Drugs of Abuse Reagent Market Forecast by Assay
France, Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
France, Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
France, Major Suppliers of Immunodiagnostic Products, Estimated Market Shares